Cargando…

Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?

Detalles Bibliográficos
Autores principales:	Stolf, N, Fiorelli, A, Lorenço, D, Barbieri, L, Tavares, E, Maranhão, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844497/ http://dx.doi.org/10.1186/1749-8090-8-S1-O149

Ejemplares similares

Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model
por: Fiorelli, A.I., et al.
Publicado: (2017)

Far-Infrared Therapy Decreases Orthotopic Allograft Transplantation Vasculopathy
por: Lin, Yi-Wen, et al.
Publicado: (2022)

Multiparametric cardiovascular magnetic resonance assessment of cardiac allograft vasculopathy
por: Miller, Christopher A, et al.
Publicado: (2014)

Combined effects of the hedgehog pathway inhibitor LDE225 and nilotinib in a random mutagenesis screen
por: Tauchi, Tetsuzo
Publicado: (2012)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Renaming NAFLD to MAFLD: Could the LDE System Assist in This Transition?
por: Lonardo, Amedeo
Publicado: (2021)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Sternal allograft transplantation for anterior chest wall reconstruction
por: Asadi, N, et al.
Publicado: (2013)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cardiac allograft vasculopathy: diagnosis, therapy, and prognosis
por: Skorić, Boško, et al.
Publicado: (2014)

Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

The role of everolimus in treatment of cardiac allograft vasculopathy
por: Watanabe, Tetsu
Publicado: (2013)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Novel formulation of a methotrexate derivative with a lipid nanoemulsion
por: Moura, Juliana A, et al.
Publicado: (2011)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19
por: Parikh, Neil U., et al.
Publicado: (2023)

What is the optimal prophylaxis for treatment of cardiac allograft vasculopathy?
por: Kobashigawa, Jon
Publicado: (2000)

Correction to: Coronary CTA for Surveillance of Cardiac Allograft Vasculopathy
por: Shah, Nishant R., et al.
Publicado: (2018)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis
por: Mello, Suzana B V, et al.
Publicado: (2016)

Inhibition of Chemokine-Glycosaminoglycan Interactions in Donor Tissue Reduces Mouse Allograft Vasculopathy and Transplant Rejection
por: Dai, Erbin, et al.
Publicado: (2010)

Diagnosis of chronic allograft vasculopathy using semiquantitative stress perfusion CMR in heart transplant patients
por: Schwid, Madeline, et al.
Publicado: (2016)

Sodium Sulfite Exacerbates Allograft Vasculopathy and Affects Tryptophan Breakdown in Murine Heterotopic Aortic Transplantation
por: Sucher, Robert, et al.
Publicado: (2019)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
por: Civieri, Giovanni, et al.
Publicado: (2023)

Vasculopathy in transthyretin Val30Met familial amyloid polyneuropathy
por: Koike, Haruki, et al.
Publicado: (2015)

Intra-articular methotrexate associated to lipid nanoemulsions: anti-inflammatory effect upon antigen-induced arthritis
por: Mello, Suzana BV, et al.
Publicado: (2013)

Functional evaluation of patients treated with osteochondral allograft transplantation for post-traumatic ankle arthrosis
por: Berti, L, et al.
Publicado: (2008)

Diagnosis of cardiac allograft vasculopathy in heart transplant patients using a pixelated stress perfusion analysis
por: Hanna, Alexander Benjamin
Publicado: (2019)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients
por: Mahmoodurrahman, Mohammed, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
por: Aleksova, Natasha, et al.
Publicado: (2021)

A reproducible mouse model of chronic allograft nephropathy with vasculopathy
por: Zarjou, Abolfazl, et al.
Publicado: (2012)

Cardiac Allograft Vasculopathy: A Donor or Recipient Induced Pathology?
por: van den Hoogen, Patricia, et al.
Publicado: (2015)

Vascular rejection in cardiac allograft vasculopathy: Impact on graft survival
por: Nair, Nandini
Publicado: (2022)

Epicardial fat volume is related to the degree of cardiac allograft vasculopathy
por: Roest, Stefan, et al.
Publicado: (2022)

Análisis del Dominio de la Robótica para la propuesta de un LDE /
por: Cuéllar Hernández, Leticia
Publicado: (2002)

Endothelial biomarkers in patients with familial Mediterranean fever associated vascular disease and vasculopathy
por: Sargsyan, Y, et al.
Publicado: (2015)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_em1khmur1nk07nra2mt3o5vgh3